Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Appl Physiol (1985) ; 96(5): 1674-80, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-14698995

RESUMO

Pulmonary surfactant is a mixture of phospholipids ( approximately 90%) and surfactant-associated proteins (SPs) ( approximately 10%) that stabilize the lung by reducing the surface tension. One proposed mechanism by which surfactant is altered during acute lung injury is via direct oxidative damage to surfactant. In vitro studies have revealed that the surface activity of oxidized surfactant was impaired and that this effect could be overcome by adding SP-A. On the basis of this information, we hypothesized that animals receiving oxidized surfactant preparations would exhibit an inferior physiological and inflammatory response and that the addition of SP-A to the oxidized preparations would ameliorate this response. To test this hypothesis, mechanically ventilated, surfactant-deficient rats were administered either bovine lipid extract surfactant (BLES) or in vitro oxidized BLES of three doses: 10 mg/kg, 50 mg/kg, or 10 mg/kg + SP-A. When instilled with 10 mg/kg normal surfactant, the rats had a significantly superior arterial Po2 responses compared with the rats receiving oxidized surfactant. Interestingly, increasing the dose five times mitigated this physiological effect, and the addition of SP-A to the surfactant preparation had little impact on improving oxygenation. There were no differences in alveolar surfactant pools and the indexes of pulmonary inflammation between the 10 mg/kg dose groups, nor was there any differences observed between either of the groups supplemented with SP-A. However, there was significantly more surfactant and more inflammatory cytokines in the 50 mg/kg oxidized BLES group compared with the 50 mg/kg BLES group. We conclude that instillation of an in vitro oxidized surfactant causes an inferior physiological response in a surfactant-deficient rat.


Assuntos
Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Pneumonia/induzido quimicamente , Surfactantes Pulmonares/metabolismo , Animais , Artérias , Líquido da Lavagem Broncoalveolar/química , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Instilação de Medicamentos , Interleucina-6/metabolismo , Masculino , Oxigênio/sangue , Pressão Parcial , Proteína A Associada a Surfactante Pulmonar/farmacologia , Proteínas Associadas a Surfactantes Pulmonares/administração & dosagem , Proteínas Associadas a Surfactantes Pulmonares/farmacologia , Ratos , Ratos Sprague-Dawley , Fator de Necrose Tumoral alfa/metabolismo
2.
J Appl Physiol (1985) ; 94(3): 975-82, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12571129

RESUMO

Mechanical ventilation is a necessary intervention for patients with acute lung injury. However, mechanical ventilation can propagate acute lung injury and increase systemic inflammation. The exposure to >21% oxygen is often associated with mechanical ventilation yet has not been examined within the context of lung stretch. We hypothesized that mice exposed to >90% oxygen will be more susceptible to the deleterious effects of high stretch mechanical ventilation. C57B1/6 mice were randomized into 48-h exposure of 21 or >90% oxygen; mice were then killed, and isolated lungs were randomized into a nonstretch or an ex vivo, high-stretch mechanical ventilation group. Lungs were assessed for compliance and lavaged for surfactant analysis, and cytokine measurements or lungs were homogenized for surfactant-associated protein analysis. Mice exposed to >90% oxygen + stretch had significantly lower compliance, altered pulmonary surfactant, and increased inflammatory cytokines compared with all other groups. Our conclusion is that 48 h of >90% oxygen and high-stretch mechanical ventilation deleteriously affect lung function to a greater degree than stretch alone.


Assuntos
Pulmão/metabolismo , Consumo de Oxigênio/fisiologia , Oxigênio/toxicidade , Respiração Artificial/efeitos adversos , Animais , Western Blotting , Líquido da Lavagem Broncoalveolar/citologia , Citocinas/metabolismo , Densitometria , Relação Dose-Resposta a Droga , Ensaio de Imunoadsorção Enzimática , Interleucina-6/análise , Interleucina-6/biossíntese , Complacência Pulmonar/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Oxigênio/administração & dosagem , Fosfatidilcolinas/metabolismo , Surfactantes Pulmonares/metabolismo , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Irrigação Terapêutica , Fator de Necrose Tumoral alfa/análise , Fator de Necrose Tumoral alfa/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA